High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma. [electronic resource]
Producer: 20040106Description: 331-6 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- administration & dosage
- Disease-Free Survival
- Drug Therapy, Combination
- Female
- Granulocyte Colony-Stimulating Factor -- adverse effects
- Humans
- Ifosfamide -- administration & dosage
- Male
- Mesna -- administration & dosage
- Mesothelioma -- drug therapy
- Middle Aged
- Pleural Neoplasms -- drug therapy
- Protective Agents -- administration & dosage
- Recombinant Proteins
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.